Technical Analysis for HELX - Franklin Genomic Advancements ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.47% | |
| Narrow Range Bar | Range Contraction | 0.47% | |
| Stochastic Reached Overbought | Strength | 0.47% | |
| Gapped Up | Strength | 0.47% | |
| Overbought Stochastic | Strength | 0.47% | |
| Up 3 Days in a Row | Strength | 0.47% | |
| Narrow Range Bar | Range Contraction | 1.48% | |
| MACD Bullish Signal Line Cross | Bullish | 1.68% | |
| Gapped Up | Strength | 1.68% | |
| Volume Surge | Other | 3.41% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 2 hours ago |
| Rose Above 20 DMA | 3 days ago |
| 60 Minute Opening Range Breakout | 3 days ago |
| Rose Above Previous Day's High | 3 days ago |
| Up 1% | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life.
Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine
Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment
Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovation
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Genetics Portfolio Management Quality Of Life DNA DNA Sequencing Personalized Medicine
Classification
Keywords: Exchange Traded Fund ETF Biotechnology Life Sciences Biology Emerging Technologies Molecular Biology Genetics Portfolio Management Quality Of Life DNA DNA Sequencing Personalized Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 32.921 |
| 52 Week Low | 25.26 |
| Average Volume | 730 |
| 200-Day Moving Average | 29.83 |
| 50-Day Moving Average | 31.74 |
| 20-Day Moving Average | 30.67 |
| 10-Day Moving Average | 30.36 |
| Average True Range | 0.36 |
| RSI (14) | 50.50 |
| ADX | 23.78 |
| +DI | 42.23 |
| -DI | 45.11 |
| Chandelier Exit (Long, 3 ATRs) | 31.32 |
| Chandelier Exit (Short, 3 ATRs) | 30.39 |
| Upper Bollinger Bands | 32.27 |
| Lower Bollinger Band | 29.06 |
| Percent B (%b) | 0.59 |
| BandWidth | 10.47 |
| MACD Line | -0.35 |
| MACD Signal Line | -0.45 |
| MACD Histogram | 0.1004 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 31.02 | ||||
| Resistance 3 (R3) | 31.02 | 30.99 | 31.01 | ||
| Resistance 2 (R2) | 30.99 | 30.97 | 30.99 | 31.00 | |
| Resistance 1 (R1) | 30.97 | 30.96 | 30.98 | 30.97 | 31.00 |
| Pivot Point | 30.94 | 30.94 | 30.94 | 30.94 | 30.94 |
| Support 1 (S1) | 30.92 | 30.92 | 30.93 | 30.92 | 30.89 |
| Support 2 (S2) | 30.89 | 30.91 | 30.89 | 30.89 | |
| Support 3 (S3) | 30.87 | 30.89 | 30.88 | ||
| Support 4 (S4) | 30.87 |
